Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Automated Cell Separation Achieved for Three Cell Types Simultaneously

By BiotechDaily International staff writers
Posted on 05 May 2014
Print article
Image: New LIAISON Ixt/Arrow CellSep Advanced provides rapid, automated cell separation for up to three cell types in a single run (Photo courtesy of DiaSorin).
Image: New LIAISON Ixt/Arrow CellSep Advanced provides rapid, automated cell separation for up to three cell types in a single run (Photo courtesy of DiaSorin).
The automated isolation of cells directly from whole blood or buffy coat is based on magnetic bead technology.

DiaSorin (Saluggia, Italy) has launched LIAISON Ixt/Arrow CellSep Advanced, which can isolate up to 3 cell types per sample in just 32 minutes per cell type, offering significant time savings compared to manual cell separation methods.

CellSep Advanced is designed for use on the LIAISON Ixt/Arrow instrument for the separation of 1, 2, or 3 cell types in up to 12 samples at a time. Requiring minimal hands-on intervention CellSep Advanced produces good yields of purified cell preparations ready for use in a wide range of downstream applications, including lineage-specific chimerism analysis. The Ixt/Arrow automated platform also minimizes human error and ensures reproducibility between runs for consistent and reliable downstream analysis.

The LIAISON Ixt/Arrow instrument can also be used for DNA extraction using the Ixt/Arrow Blood DNA extraction kit, ensuring streamlined processing of samples and, by reducing instrumentation requirements, saving valuable bench space in the laboratory.

DiaSorin is a leader in the field of biotechnology. For over 40 years the company has been developing, producing, and marketing reagent kits for in vitro diagnostics worldwide. With their most recent acquisition of the NorDiag Group, DiaSorin gains access to the nucleic acid isolation and cell separation markets. Its line of products used by diagnostic laboratories that are part of hospital facilities or operate independently (private diagnostic services laboratories) can meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology, and endocrinology.

Related Links:

DiaSorin



Print article

Channels

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.